⚠ FDA NOTICE: These products are NOT FDA approved for human use. Sold for research purposes only. Not for human consumption.
🎟 Have a code? Apply for member pricing:

Research Compound Catalog

Browse our planned peptide formulations. None are currently available for purchase.

⚠ Reminder: These products are NOT FDA approved and cannot be purchased at this time. Prices shown are projected retail prices for when approval is obtained.
🍴
Cagrilintide
5 mg

Cagrilintide

$70.00

Vial Size: 5 mg

Long-acting amylin analog. Appetite suppression; pairs with semaglutide as CagriSema.

SKU: PP-CAG-5 Category:

Description

Cagrilintide – 5 mg

Cagrilintide is a long-acting amylin analog. Amylin co-released with insulin slows gastric emptying and promotes satiety. Often combined with semaglutide (“CagriSema”) for compounded weight loss.

Common Applications:

  • Appetite suppression
  • Weight loss (especially in CagriSema combination)
  • Glucose control
  • Plateau-breaking when GLP-1 alone stalls

Reference Dosing:

Start 0.16 mg/week, titrate by 0.16-0.32 mg every 4 weeks up to 2.4 mg/week.

Reviews

There are no reviews yet.

Be the first to review “Cagrilintide”

Your email address will not be published. Required fields are marked *

Important Notice

These products are NOT currently FDA approved.

The peptide compounds described on this site are for informational and research purposes only. They are not intended to diagnose, treat, cure, or prevent any disease.

The information provided is based on current scientific research and literature regarding peptide compounds. These products are presented as a preview of what may become available pending FDA regulatory approval.

Always consult with a qualified healthcare professional before starting any new supplement or wellness program.

Related products